Point-of-care nucleic acid tests: assays and devices
Nanoscale · 2023
DOI: 10.1039/d2nr05385c ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nanoscale, 2023. Verfasst von Ofer I Wilner und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel. yweizmann@bgu.ac.il. Hauptthemen laut MEDLINE: COVID-19, Nucleic Acids. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 75 Literaturangaben. Gefördert von: Israel Science Foundation, National Natural Science Foundation of China.
Abstract (Originalsprache)
The COVID-19 pandemic has emphasized the need for accurate, quick, and portable diagnostic devices at the point of care. First, we reviewed the history of nucleic acid diagnostics, its current state, and an outlook for future developments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel. yweizmann@bgu.ac.il.
- Ilse Katz Institute for Nanotechnology Science, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel.
- Goldman Sonnenfeldt School of Sustainability and Climate Change, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel.
Förderung
- Israel Science Foundation
- National Natural Science Foundation of China
Zitieren
APA
Wilner, O. I., Yesodi, D., & Weizmann, Y. (2023). Point-of-care nucleic acid tests: assays and devices. Nanoscale. https://doi.org/10.1039/d2nr05385c
Vancouver
Wilner OI, Yesodi D, Weizmann Y. Point-of-care nucleic acid tests: assays and devices. Nanoscale. 2023. doi:10.1039/d2nr05385c
BibTeX
@article{Wilner2023,
author = {Wilner, Ofer I and Yesodi, Doron and Weizmann, Yossi},
title = {Point-of-care nucleic acid tests: assays and devices},
journal = {Nanoscale},
year = {2023},
doi = {10.1039/d2nr05385c}
}
EUVIMED